VAERS reports by lot

GSK Hepatitis A lot 9P9B5: VAERS reports

26 VAERS reports list lot 9P9B5 as a GSK Hepatitis A vaccine, received between 2020-10-22 and 2022-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)650%
Neurological325%
Cardiac / Cardiovascular18%
General / Systemic (non-local)18%
Injection-site / Local reaction18%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Ohio3
Pennsylvania2
North Carolina2
Montana2
Florida1
Missouri1
Kansas1
Tennessee1
Arizona1
Georgia1
North Dakota1

Reports by month received

2020-101
2021-011
2021-021
2021-042
2021-061
2021-071
2021-082
2021-101
2021-112
2021-121
2022-026
2022-033
2022-052
2022-062

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.